A second example of anti-Esa, an antibody to a high-incidence Cromer antigen

Immunohematology

Volumn 12, Issue 3, 1996, Pages 112-114

  Reid, M E ^a   Makfoe, R A ^b   Mueller, A L ^b   Arndt, P A ^b   Sausais, L ^c   Spruell, E ^d  

^a Immunohematology Laboratory   (United States)

^b AMERICAN RED CROSS BLOOD SERVICES   (United States)

^c NEW YORK BLOOD CENTER   (United States)

^d Gamma Biologicals Inc   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

AGED; ANTIBODY DETECTION; ANTIGEN ANTIBODY REACTION; ANTIGEN RECOGNITION; ARTICLE; BLOOD GROUP; BLOOD TRANSFUSION; CASE REPORT; HUMAN; MALE; PRIORITY JOURNAL;

EID: 0029786414     PISSN: 0894203X     EISSN: None     Source Type: Journal    
DOI: 10.21307/IMMUNOHEMATOLOGY-2019-760     Document Type: Article

References (18)

1. Telen MJ, Hall SE, Green AM, Moulds J J, Rosse WF. Identification of human erythrocyte blood group antigens on decay-accelerating factor (DAF) and an erythrocyte phenotype negative for DAF. J Exp Med 1988;167:1993-8.
2. Spring FA, Judson PA, Daniels GL, Parsons SF, Mallinson G, Anstee DJ. A human cell-surface glycoprotein that carries Cromer-related blood group antigens on erythrocytes and is also expressed on leucocytes and platelets. Immunology 1987;62:307-13.
3. Petty AC, Daniels GL, Anstee DJ, Tippett P. Use of the MATEA technique to confirm the relationship between the Cromer antigens and decay-accelerating factor and to assign provisionally antigens to the short-consensus repeats. Vox Sang 1993;65:309-15.
4. Lublin DM, Mallinson G, Poole J, et al. Molecular basis of reduced or absent expression of decay-accelerating factor in Cromer blood group phenotypes. Blood 1994;84:1276-82.
5. Telen MJ, Rao N, Udani M, Thompson ES, Kaufman RM, Lublin DM. Molecular mapping of the Cromer blood group Cr1 and Tc* epitopes of decay-accelerating factor: toward the use of recombinant antigens in immunohematology. Blood 1994;84: 3205-11.
6. Daniels G. Cromer-related antigens: blood group determinants on decay-accelerating factor. Vox Sang 1989;56:205-11.
7. Stony JR. Serology and genetics of the Cromer blood group system. In: Moulds JM, Laird-Fryer B, eds. Blood groups: Ch/Rg, Kn/McC/Yk, Cromer. Bethesda, MD: American Association of Blood Banks, 1992:31-43.
8. Reid ME, Green CA, Hoffer J, 0 y e n R. Effect of pronase on high-incidence blood group antigens and the prevalence of antibodies to pronase-treated erythrocytes. (I n press, Immunohematology 1996).
9. Rosse WF. Phosphatidylinositol-linked proteins and paroxysmal nocturnal hemoglobinuria. Blood 1990;75:1595-601.
10. Telen MJ, Rosse WF, Parker CJ, Moulds MK, Moulds J J . Evidence that several high-frequency human blood group antigens reside on phosphatidylinositol-linked erythrocyte membrane proteins. Blood 1990;75:1404-7.
11. Daniels GL, Okubo Y, Yamaguchi H, Seno T, Ikuta M. UMC, another Cromer-related blood group antigen. Transfusion 1989;29:794-7.
12. Tregellas WM. Description of a new blood group antigen, E s a . Abstracts of the 18th Congress of the International Society of Blood Transfusion, Basel, Karger, 1984:163.
13. Daniels GL. Characteristics of Cromer-related antibodies (abstract). Transfusion 1983;23:410.
14. American Red Cross. Immunohematology methods and procedures. Rockville, MD: American Red Cross National Reference Laboratory, 1993.
15. Postoway N, Garratty G. Standardization of IgG subclass antiserums for use with sensitized red cells. Transfusion 1983;23:398-400.
16. Nance SJ, Arndt P, Garratty G. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987;27:449-52.
17. Reid ME, Chandrasekaran V, Sausais L, Pierre J, Bullock R. Disappearance of antibodies to Cromer blood group system antigens during mid-pregnancy. Vox Sang (in press).
18. Mourant AE, Kopec AC, Domaniewska-Sobczak K. The distribution of the human blood groups and other polymorphisms. London: Oxford University Press, 1976:124.